Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novell
Novell
ImmunoCellular Therapeutics Licenses Novel Immunotherapeutic Target EphA2 from University of Pittsburgh
Thu, 03/22/12 - 09:06 pm
ImmunoCellular Therapeutics
Novell
University
Zanett, Novell: Early Volume Plays
TheStreet.com
Mon, 03/22/10 - 10:37 am
Zanett
Novell
BioDelivery Sciences
PharmAthene
